Elsalys Biotech is a startup based in France, most recent round Series-c-plus, 1 tracked investor.
Based in France, Elsalys Biotech is a startup founded in 2015. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Elsalys Biotech is a clinical-stage biotechnology company developing novel immunotherapies for cancer. It focuses on targeting the tumor microenvironment and immune checkpoints to create new treatment options.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.